Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

rhEndostatin Protein Involving Pediatric Patients With Cancer

This study has been terminated.
(Lack of drug supply)
Boston Children’s Hospital
Information provided by:
Dana-Farber Cancer Institute Identifier:
First received: September 9, 2005
Last updated: December 21, 2007
Last verified: December 2007
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2005
  Primary Completion Date: January 2005 (Final data collection date for primary outcome measure)